Earlier studies demonstrated that treatment with trichostatin A (TSA), a pan HDAC inhibitor (HDACi) for both class I and class II HDACs, attenuates renal fibrosis in unilateral ureteral obstruction (UUO) mouse model [41]. This evidence concerns the gene HDAC9 and renal fibrosis.